NM_001329943.3(KIAA0586):c.3G>A (p.Met1Ile) AND multiple conditions
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Sep 1, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002036016.4
Allele description [Variation Report for NM_001329943.3(KIAA0586):c.3G>A (p.Met1Ile)]
NM_001329943.3(KIAA0586):c.3G>A (p.Met1Ile)
Condition(s)
-
Erimyzon claviformis voucher NYSM:68828 cytochrome oxidase subunit 1 (COI) gene,...
Erimyzon claviformis voucher NYSM:68828 cytochrome oxidase subunit 1 (COI) gene, partial cds; mitochondrialgi|2024652117|gb|MT019584.1|Nucleotide
-
PREDICTED: Homo sapiens protein tyrosine kinase 2 (PTK2), transcript variant X40...
PREDICTED: Homo sapiens protein tyrosine kinase 2 (PTK2), transcript variant X40, mRNAgi|2217372712|ref|XM_047422052.1|Nucleotide
-
focal adhesion kinase 1 isoform 56 [Homo sapiens]
focal adhesion kinase 1 isoform 56 [Homo sapiens]gi|1915706805|ref|NP_001374534.1|Protein
-
Sequence 431 from Patent EP2107127
Sequence 431 from Patent EP2107127gi|261385763|emb|HC007186.1||pat|EP 127|431Nucleotide
-
PREDICTED: Homo sapiens mitofusin 2 (MFN2), transcript variant X6, mRNA
PREDICTED: Homo sapiens mitofusin 2 (MFN2), transcript variant X6, mRNAgi|2462516106|ref|XM_054339954.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024